Michael Laffan is Professor of Haemostasis and Thrombosis in the department of haematology.He trained in medicine at the University of Oxford and trained in haematology at the Hammersmith and Royal Free hospitals. His principal research interests are the structure function relationship of von Willebrand factor, in particular the role of glycosylation, and the mechanisms and regulation of thrombin generation. He is director of the Hammersmith Hospital Haemophilia centre and is responsible for postgraduate education in haematology.
et al., 2017, Should we abandon the APTT for monitoring unfractionated heparin?, Thrombosis Research, Vol:157, ISSN:0049-3848, Pages:157-161
Arachchillage DRJ, Laffan M, 2017, Pathogenesis and management of antiphospholipid syndrome, British Journal of Haematology, Vol:178, ISSN:0007-1048, Pages:181-195
Arachchillage DRJ, Laffan M, 2017, Can Mean Platelet Volume Be Used as a Predictor of Vascular Disease? Problems and Pitfalls, Seminars in Thrombosis and Hemostasis, Vol:43, ISSN:0094-6176, Pages:599-608
et al., 2017, The Effect of Iron Status on Risk of Coronary Artery Disease A Mendelian Randomization Study-Brief Report, Arteriosclerosis Thrombosis and Vascular Biology, Vol:37, ISSN:1079-5642, Pages:1788-+
et al., 2017, Thromboelastography (TEG (R)) demonstrates that tinzaparin 4500 international units has no detectable anticoagulant activity after caesarean section, International Journal of Obstetric Anesthesia, Vol:29, ISSN:0959-289X, Pages:50-56